Skip to main content

Table 1 The effect of TRPA1 antagonist 50 μg HC-030031 on cystometry parameters of inflammatory rats

From: Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

       Compliance (μl/mmHg) N-VC (number)
   BP (mmHg) PT (mmHg) MP (mmHg) ICI (min)
  No-treatment 13.11 ± 6.14 15.86 ± 6.25 24.33 ± 8.78 3.92 ± 1.41 139.10 ± 49.47 0.25 ± 0.5
Control Treatment 11.24 ± 3.11 14.25 ± 3.44 21.54 ± 5.34 4.08 ± 1.32 159.15 ± 76.02 0
  Recovery 11.17 ± 3.08 14.86 ± 3.48 21.53 ± 5.14 3.90 ± 0.74 146.46 ± 65.47 0
  No-treatment 10.10 ± 5.74 11.83 ± 6.16 19.11 ± 8.01 2.28 ± 0.51 124.78 ± 49.52 3.25 ± 0.5
Cystitis Treatment 7.70 ± 3.29 9.83 ± 3.05 17.29 ± 6.87 4.14 ± 1.05* 98.12 ± 25.15 1.25 ± 0.50**
  Recovery 7.39 ± 3.75 10.05 ± 4.25 15.72 ± 7.00 3.10 ± 0.31 136.80 ± 42.92 1.25 ± 0.50**
  1. Results were expressed as mean ± standard error. The “*” or “**” represented the difference was significant between the treatment or recovery and no-treatment in cystometry parameters. *P < 0.05, ** P < 0.01